Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (19)

1

Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients

enthalten in: AIDS (London, England) | 2009

von De Meyer, S. | Lathouwers, E. | Dierynck, I. | +7

2

Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96

enthalten in: Antiviral therapy | 2009

von Arastéh, K. | Yeni, P. | Pozniak, A. | +7

3

Characterization of virologic failure patients on darunavir-ritonavir in treatment-experienced patients

enthalten in: Aids | 2009

von De Meyer, S. | Lathouwers, E. | Dierynck, I. | +7

4

Influence of baseline protease inhibitor resistance on the efficacy of darunavir/ritonavir or lopinavir/ritonavir in the TITAN trial

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2008

von De Meyer, S. | Hill, A. | Picchio, G. | +3

CommentOn: AIDS. 2007 Oct 18;21(16):2245-8. - PMID 18090054

5

Efficacy of once-daily darunavir/ritonavir 800/100 mg in HIV-infected, treatment-experienced patients with no baseline resistance-associated mutations to darunavir

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2008

von De Meyer, S. | Spinosa-Guzman, S. | Vangeneugden, T. | +2

6

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48

enthalten in: AIDS (London, England) | 2008

von Ortiz, R. | Dejesus, E. | Khanlou, H. | +9

7

Resistance profile of darunavir : combined 24-week results from the POWER trials

enthalten in: AIDS research and human retroviruses | 2008

von de Meyer, S. | Vangeneugden, T. | van Baelen, B. | +5

8

Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients"

enthalten in: AIDS (London, England) | 2008

von Picchio, G. | De Meyer, S. | de Béthune, M.

CommentOn: AIDS. 2007 May 31;21(9):1210-3. - PMID 17502734

9

Response to “Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients”

enthalten in: Aids | 2008

von Picchio, G. | De Meyer, S. | de Béthune, M.

10

Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials

enthalten in: Aids research and human retroviruses | 2008

von de Meyer, S. | Vangeneugden, T. | van Baelen, B. | +5